Update: Application of Cal/OSHA Aerosol Transmissible Disease Standards in Laboratories - PowerPoint PPT Presentation

1 / 36
About This Presentation
Title:

Update: Application of Cal/OSHA Aerosol Transmissible Disease Standards in Laboratories

Description:

Planning for pandemic flu and other surge events ... http://www.dir.ca.gov/samples/search/query.htm. Standards Board Proposed Regulations: ... – PowerPoint PPT presentation

Number of Views:183
Avg rating:3.0/5.0
Slides: 37
Provided by: deborah195
Category:

less

Transcript and Presenter's Notes

Title: Update: Application of Cal/OSHA Aerosol Transmissible Disease Standards in Laboratories


1
Update Application of Cal/OSHA Aerosol
Transmissible Disease Standards in Laboratories
  • Deborah Gold, dgold_at_dir.ca.gov
  • Bob Nakamura, bnakamura_at_dir.ca.gov
  • October 2, 2009

2
Every Employer shall furnish employment and a
place of employment that is safe and healthful
for the employees therein. California Labor Code
Section 6400
3
Tuberculosis Cases in California, 1980-2008
TB Incidence still well over national average
rate of decline has slowed.
CDPH
4
Counties in CA with increased TB incidence
2007-2008
Source CDPH
5
Why an ATD standard
  • Existing aerosol transmissible diseases such as
    TB health care workers still at increased risk
  • Experience of Canada and Asia with SARS
  • Planning for pandemic flu and other surge events
  • Incidents of laboratory transmission and near
    misses
  • Increased research on BSL 3 and above

6
(No Transcript)
7
Four Types of Employers
  • Hospitals, other work settings which perform
  • evaluation, diagnosis, treatment, transport,
    housing or management of persons requiring
    airborne infection isolation
  • high hazard procedures performed on suspect or
    confirmed cases
  • decontamination or management of persons
    contaminated as a result of a release of
    biological agents
  • autopsies or embalming procedures on human
    cadavers potentially infected with aerosol
    transmissible pathogens.

8
Four Types of Employers (cont)
  • Patients or clients are screened for airborne
    infectious diseases and referred if indicated
    (Referring Employers subsection (c))
  • Laboratories (subsection (f))
  • Conditionally Exempt Employers medical
    specialty practices, dentists that dont treat
    ATDs, dont perform high hazard procedures on
    those patients, and have screening and referral
    procedures
  • Separate subsections allow people to focus on
    requirements that apply to them

9
(No Transcript)
10
Laboratory Subsection
  • Control of person to person transmission is
    different than laboratory aerosols.
  • Infectious organisms may become airborne in labs
    that are not naturally transmitted by that route.
  • Biosafety professionals have already established
    consensus guidelines, e.g. BMBL
  • We want to prevent an increase in laboratory
    risks due to increasing research on emerging
    pathogens and homeland security issues.

11
Some Recent Lab Exposures
  • Brucellosis in clinical lab worker in southern
    California
  • Anthrax at research facility
  • TB conversions related to exposure chamber
  • Inadvertent distribution of H2N2 influenza virus
  • Tularemia

12
Aerosol Transmissible Pathogens Laboratory
  • Listed in Appendix D
  • List derived from BMBL and HICPAC guidelines
  • BMBL recommends BSL 3 or above
  • Biosafety Officer recommends
  • Novel or Unknown Pathogen

13
Novel or Unknown Pathogen
  • Causes serious human disease
  • Credible evidence that the pathogen is
    transmissible to humans by aerosols
  • The disease agent is
  • (a) A newly recognized pathogen, or
  • (b) A newly recognized variant that differs
    significantly in virulence or transmissibility,
    or
  • (c) A recognized pathogen that has been recently
    introduced into the human population, or
  • (d) A not yet identified pathogen.
  • Pandemic flu strain is a novel pathogen, seasonal
    influenza is not

14
Laboratories -- Application
  • Laboratories that perform procedures that
    aerosolize ATPs-L
  • If employees have direct contact with infectious
    people (cases or suspected cases), other sections
    also apply.
  • The presence of ATPs-L requires the development
    of a biosafety plan (institutional risk
    assessment)

15
Risk Assessment
  • Done by a biosafety officer
  • Consistent with BMBL, Section II
  • For each agent and procedure
  • Record safe handling practices in biosafety plan
  • Trade secret info need not be recorded in plan
  • Control measures consistent with risk

16
Zoonotics Section 5199.1
  • Applies to any place where employees are exposed
    to animals, or their products or wastes
  • Under normal circumstances address under IIPP
    (Section 3203)
  • Existing BBP regulation applies to animals
    infected with BBP
  • Existing respiratory protection standard (5144)
    applies to exposures to infectious aerosols.

17
Risk Assessment VivariumsSection 5199.1
  • Applies to all vertebrate animal research
    facilities
  • Risk assessment and control consistent with BMBL
  • BMBL references NIH and ILAR guidelines for
    general conditions in anitmal facilities
  • Tissues and samples to comply with ATD standard,
    section 5199(f)

18
Hierarchy of Controls
  • Engineering
  • Use alternative processes
  • Primary and secondary containment
  • Work Practices
  • Personal and Respiratory Protection, if necessary
  • Consistent with BMBL

19
Biosafety Officers Are Key
  • Assess risk and specify control measures based on
    the specific pathogens and processes in the lab
  • Must have necessary knowledge, authority and
    responsibility
  • Audit and correct hazards
  • Review the plan
  • Be consulted regarding changes to facility that
    would effect biosafety

20
Elements of Biosafety Plan (1)
  • Lists of jobs, tasks, procedures, ATPs-L
  • Requirement to treat incoming materials as
    containing virulent pathogen until verify
    attenuated
  • Engineering controls (e.g. laboratory
    construction, biosafety cabinets)
  • Safe handling procedures
  • Decontamination and disinfection
  • PPE and Respirators if necessary

21
Elements of Biosafety Plan (2)
  • Emergency procedures, including report to local
    health officer
  • Medical services
  • Training
  • Employee involvement in review of plan
  • Inspection procedures and hazard correction
  • BSO to review design and construction plans for
    review of ATPs-L control

22
Medical Services
  • Vaccinations
  • Exposure incidents notification and medical
    follow-up
  • LTBI surveillance not required in research labs
    not working with materials reasonably anticipated
    to contain TB
  • Respirator evaluations, if applicable
  • Ensure confidentiality

23
Vaccinations
  • Health Care Workers MMR, Tdap, Varicella,
    influenza (HBV per 5193)
  • Laboratory workers pathogen/material/risk-benefi
    t based on BMBL/ACIP recommendations
  • BMBL recommends medical consultation for
    employees at BSL 3 and above
  • Seasonal flu effective now
  • Other vaccination requirements effective
    September 1, 2010

24
Recordkeeping
  • Medical records including vaccination, LTBI as
    applicable
  • Training
  • Plan review
  • Inspection and testing of engineering controls,
    such as ventilation systems and biosafety
    cabinets
  • Respiratory Protection per 5144

25
IIPP
  • Written health and safety program
  • Responsible person
  • System of compliance with safety rules
  • Hazard Identification/Evaluation and Correction
  • Communication
  • Accident/illness investigation
  • Training
  • Recordkeeping

26
Zoonotics
  • Subsection (c) applies to animals under
    quarantine order etc. from USDA, CDFA
  • Requires use of respirators and change rooms when
    entering enclosed areas.
  • Subsection (d) applies to eradication and clean
    up operations, disinfection of areas containing
    wastes from animals infected with zoonotic ATPs.

27
Vertebrate Animal Research Facilities ABSL 3 or
above
  • MUST Comply with Subsection (d)
  • Written work plan, assessment of all risks
    (including chemical, physical and safety hazards)
    and control measures
  • Restricted areas
  • Contaminant reduction zone
  • Supervision
  • Recording of entry

28
Vertebrate Animal Research Facilities ABSL 3 or
above (cont)
  • Respirators
  • Decontamination, disposal
  • Change facilities
  • Medical services
  • Procedures for access to drinking water and
    sanitation facilities
  • Training
  • Procedures for toxic or asphyxiant gases, if
    applicable

29
Why is Cal/OSHA in My Lab?
  • Cal/OSHA is the agency designated by law to
    protect employees at work
  • Cal/OSHA provides a way for employees to get an
    independent review of safety issues at work, and
    to get hazards corrected in a timely manner
  • Cal/OSHA experience is that NIH guidelines and
    other audit programs do not prevent significant
    failures in occupational health and safety
    programs.
  • Its our job.

30
H1N1
  • Laboratory capacity was overwhelmed in the first
    month
  • Reduction in testing recommendations
  • Reduction in laboratory precautions

31
Interim Biosafety Guidance 2009-H1N1 Influenza A
Virus CDC 8-15-09
  1. Splash Protection for performing rapid
    immunoassay tests
  2. Class II biosafety cabinet (BSC) in BSL-2 lab for
    more complex procedures (e.g., direct or indirect
    fluorescent antibody tests DFA, IFA, culture,
    molecular assays), a Class II biosafety cabinet
    (BSC) in a biosafety level-2 (BSL-2) laboratory
    is required. 
  3. BSL-3 practices are no longer required for viral
    isolation. 
  4. Personal Protective Equipment -- lab coats and
    gloves

32
Rapid Tests lab or non-lab settings
  • FDA-cleared rapid immunoassay tests require
    assessment of risks for generation of aerosols or
    contact with infectious material.
  • If they do not generate aerosols, they require
    splash protection laboratory coat, gloves, eye
    protection, facemask
  • Procedures done outside a Class II BSC should be
    performed to minimize creation of splashes and/or
    aerosols.
  • Aerosol generating tests BSL-2

33
Procedures Requiring BSL-2
  • Rapid tests involving steps that could generate
    aerosols (e.g. vortexing),
  • Direct or indirect fluorescent antibody tests
    (DFA, IFA) to detect viral antigens in clinical
    specimens,
  • Growth of virus in cell culture or embryonated
    eggs,
  • Molecular-based assays,
  • General laboratory research
  • Viral isolation and all sample manipulations with
    the potential for creating an aerosol in Class II
    BSC

34
Occupational Health
  • Personnel who have had an occupational exposure
    to any infectious agent, including 2009-H1N1
    influenza A (novel H1N1), should immediately
    inform their supervisor or manager.  Antiviral
    chemoprophylaxis is available and should be
    considered.  For additional information on
    antiviral treatment visit Interim Guidance on
    Antiviral Recommendations for Patients with
    Confirmed or Suspected Swine Influenza A (H1N1)
    Virus Infection and Close Contacts

35
Benefits of Lab Section
  • Supports the role of biosafety professionals in
    labs, including risk analysis
  • Establishes a baseline level of safety and works
    against cutting safety to compete for contracts
    etc.
  • Is structured to incorporate existing biosafety
    guidelines, procedures, plans
  • Provides notice to employers and employees
    regarding Cal/OSHA requirements helps us all be
    on the same page

36
Find Cal/OSHA on the Web
  • Cal/OSHA regulations
  • http//www.dir.ca.gov/samples/search/query.htm
  • Standards Board Proposed Regulations
  • http//www.dir.ca.gov/oshsb/atdapprvdtxt.pdf
  • Advisory committee webpage
  • http//www.dir.ca.gov/dosh/DoshReg/advisory_commit
    tee.html
Write a Comment
User Comments (0)
About PowerShow.com